AnterogenCoLtd Revenue vs. Return On Equity

065660 Stock  KRW 16,950  1,380  8.86%   
Based on the measurements of profitability obtained from AnterogenCoLtd's financial statements, AnterogenCoLtd may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess AnterogenCoLtd's ability to earn profits and add value for shareholders.
For AnterogenCoLtd profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AnterogenCoLtd to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AnterogenCoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AnterogenCoLtd's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AnterogenCoLtd over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between AnterogenCoLtd's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnterogenCoLtd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnterogenCoLtd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AnterogenCoLtd Return On Equity vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AnterogenCoLtd's current stock value. Our valuation model uses many indicators to compare AnterogenCoLtd value to that of its competitors to determine the firm's financial worth.
AnterogenCoLtd is rated below average in revenue category among its peers. It is rated below average in return on equity category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AnterogenCoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnterogenCoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

AnterogenCoLtd Revenue vs. Competition

AnterogenCoLtd is rated below average in revenue category among its peers. Market size based on revenue of Pharmaceuticals industry is presently estimated at about 602.82 Billion. AnterogenCoLtd claims roughly 8.12 Billion in revenue contributing just under 2% to equities listed under Pharmaceuticals industry.

AnterogenCoLtd Return On Equity vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

AnterogenCoLtd

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
8.12 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

AnterogenCoLtd

Return On Equity

 = 

Net Income

Total Equity

 = 
-5.92
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

AnterogenCoLtd Return On Equity Comparison

AnterogenCoLtd is rated below average in return on equity category among its peers.

AnterogenCoLtd Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in AnterogenCoLtd, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AnterogenCoLtd will eventually generate negative long term returns. The profitability progress is the general direction of AnterogenCoLtd's change in net profit over the period of time. It can combine multiple indicators of AnterogenCoLtd, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.

AnterogenCoLtd Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AnterogenCoLtd. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AnterogenCoLtd position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AnterogenCoLtd's important profitability drivers and their relationship over time.

Use AnterogenCoLtd in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnterogenCoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnterogenCoLtd will appreciate offsetting losses from the drop in the long position's value.

AnterogenCoLtd Pair Trading

AnterogenCoLtd Pair Trading Analysis

The ability to find closely correlated positions to AnterogenCoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnterogenCoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnterogenCoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnterogenCoLtd to buy it.
The correlation of AnterogenCoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnterogenCoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnterogenCoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnterogenCoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AnterogenCoLtd position

In addition to having AnterogenCoLtd in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in AnterogenCoLtd Stock

To fully project AnterogenCoLtd's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AnterogenCoLtd at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AnterogenCoLtd's income statement, its balance sheet, and the statement of cash flows.
Potential AnterogenCoLtd investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although AnterogenCoLtd investors may work on each financial statement separately, they are all related. The changes in AnterogenCoLtd's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AnterogenCoLtd's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.